| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1023/B:PHAM.0000019289.61978.F5 |
| P698 | PubMed publication ID | 15070086 |
| P2093 | author name string | Steven F Dowdy | |
| Eric L Snyder | |||
| P2860 | cites work | SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP) | Q24292189 |
| Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans | Q28140638 | ||
| Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex | Q28145172 | ||
| In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis | Q28570309 | ||
| In vivo protein transduction: delivery of a biologically active protein into the mouse | Q29615482 | ||
| Cellular uptake of the tat protein from human immunodeficiency virus | Q29620627 | ||
| Intravenous TAT-Bcl-Xl is protective after middle cerebral artery occlusion in mice | Q31115814 | ||
| New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. | Q33895267 | ||
| Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. | Q33896810 | ||
| Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. | Q33944297 | ||
| The third helix of the Antennapedia homeodomain translocates through biological membranes. | Q34338497 | ||
| Protection against ischemic brain injury by protein therapeutics | Q34431022 | ||
| Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation. | Q34444788 | ||
| Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein | Q34556566 | ||
| Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes | Q34762768 | ||
| Peptide-mediated cell delivery: application in protein target validation | Q34905149 | ||
| TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors | Q37115345 | ||
| The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters | Q37278005 | ||
| Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction | Q40629590 | ||
| Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins | Q40644120 | ||
| Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake | Q40692947 | ||
| Evidence for a plasma membrane-mediated permeability barrier to Tat basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate | Q40697664 | ||
| TAT protein transduction into isolated perfused hearts: TAT-apoptosis repressor with caspase recruitment domain is cardioprotective | Q40712779 | ||
| The 104-123 amino acid sequence of the beta-domain of von Hippel-Lindau gene product is sufficient to inhibit renal tumor growth and invasion. | Q40716097 | ||
| Proteins linked to a protein transduction domain efficiently transduce pancreatic islets | Q40789934 | ||
| Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. | Q42632235 | ||
| Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells. | Q42816960 | ||
| Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. | Q43440370 | ||
| Doxorubicin-peptide conjugates overcome multidrug resistance | Q43549650 | ||
| Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. | Q43726340 | ||
| Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo | Q43804740 | ||
| Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ | Q44129457 | ||
| Transducible peptide therapy for uveal melanoma and retinoblastoma | Q44169189 | ||
| Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions | Q44193907 | ||
| Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation | Q46454374 | ||
| Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. | Q48548442 | ||
| In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation | Q60695434 | ||
| A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus | Q63343005 | ||
| Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells | Q73861944 | ||
| Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate | Q74190552 | ||
| A proapoptotic peptide for the treatment of solid tumors | Q77112307 | ||
| Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration | Q77658726 | ||
| Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice | Q77924606 | ||
| P433 | issue | 3 | |
| P921 | main subject | drug delivery | Q1392806 |
| P304 | page(s) | 389-393 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Cell penetrating peptides in drug delivery | |
| P478 | volume | 21 |
| Q42544966 | "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers |
| Q39793490 | "Soft" calcium crosslinks enable highly efficient gene transfection using TAT peptide |
| Q36110850 | A detachable coating of cholesterol-anchored PEG improves tumor targeting of cell-penetrating peptide-modified liposomes |
| Q39558788 | A modified Tat peptide for selective intracellular delivery of macromolecules |
| Q42922886 | A novel concept in antiangiogenic and antitumoral therapy: multitarget destabilization of short-lived mRNAs by the zinc finger protein ZFP36L1 |
| Q82466999 | A novel human derived cell-penetrating peptide in drug delivery |
| Q39124266 | A polymeric domain that promotes cellular internalization |
| Q38814333 | AT2R Gene Delivered by Condensed Polylysine Complexes Attenuates Lewis Lung Carcinoma after Intravenous Injection or Intratracheal Spray |
| Q42105272 | An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging |
| Q34293608 | Antibacterial activities of amphiphilic cyclic cell-penetrating peptides against multidrug-resistant pathogens |
| Q39721806 | Antiviral activity of selected antimicrobial peptides against vaccinia virus |
| Q39840364 | Application of thermally responsive elastin-like polypeptide fused to a lactoferrin-derived peptide for treatment of pancreatic cancer. |
| Q38166533 | Applications of cell-penetrating peptides for tumor targeting and future cancer therapies. |
| Q38774712 | Biodegradable "Smart" Polyphosphazenes with Intrinsic Multifunctionality as Intracellular Protein Delivery Vehicles. |
| Q36093248 | CPP2-p16MIS treatment-induced colon carcinoma cell death in vitro and prolonged lifespan of tumor-bearing mice. |
| Q39252765 | Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study |
| Q42190715 | Cell membrane penetrating function of the nuclear localization sequence in human cytokine IL-1α. |
| Q37755594 | Cell penetrating elastin-like polypeptides for therapeutic peptide delivery |
| Q42549959 | Cell permeant peptide analogues of the small heat shock protein, HSP20, reduce TGF-beta1-induced CTGF expression in keloid fibroblasts |
| Q55196079 | Cell-Penetrating Function of the Poly(ADP-Ribose) (PAR)-Binding Motif Derived from the PAR-Dependent E3 Ubiquitin Ligase Iduna. |
| Q34606888 | Cell-Penetrating Penta-Peptides (CPP5s): Measurement of Cell Entry and Protein-Transduction Activity |
| Q40808308 | Cell-penetrating peptide and antibiotic combination therapy: a potential alternative to combat drug resistance in methicillin-resistant Staphylococcus aureus. |
| Q37039034 | Cell-penetrating peptides for drug delivery across membrane barriers |
| Q37594526 | Cell-penetrating peptides: achievements and challenges in application for cancer treatment |
| Q46710298 | Cellular uptake of fluorescent labelled biotin-streptavidin microspheres |
| Q37361218 | Chemically and biologically synthesized CPP-modified gelonin for enhanced anti-tumor activity |
| Q24682407 | Chimeric RNase H-competent oligonucleotides directed to the HIV-1 Rev response element |
| Q61797303 | Combination of Cell-Penetrating Peptides with Nanoparticles for Therapeutic Application: A Review |
| Q46500463 | Comparative study of the skin penetration of protein transduction domains and a conjugated peptide. |
| Q47810720 | Convergent synthesis and cellular uptake of multivalent cell penetrating peptides derived from Tat, Antp, pVEC, TP10 and SAP. |
| Q36854231 | Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. |
| Q42563696 | Cyclodextrin-PEI-Tat Polymer as a Vector for Plasmid DNA Delivery to Placenta Mesenchymal Stem Cells |
| Q67403879 | De novo design of tunable, pH-driven conformational changes. |
| Q28087352 | Delivery of nucleic acids and nanomaterials by cell-penetrating peptides: opportunities and challenges |
| Q28547179 | Design strategies and applications of circulating cell-mediated drug delivery systems |
| Q39583280 | Design, synthesis and characterization of a new anionic cell-penetrating peptide: SAP(E). |
| Q52715734 | Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain. |
| Q38413685 | Development of protein mimics for intracellular delivery |
| Q84290722 | Dimeric cationic amphiphilic polyproline helices for mitochondrial targeting |
| Q42263968 | Effect of TAT-obestatin on proliferation, differentiation, apoptosis and lipolysis in 3T3-L1 preadipocytes |
| Q37284677 | Effects of protein transduction domain (PTD) selection and position for improved intracellular delivery of PTD-Hsp27 fusion protein formulations |
| Q40386485 | Efficient disruption and replacement of an effector gene in the oomycete Phytophthora sojae using CRISPR/Cas9. |
| Q35709116 | Endotoxin deactivation by transient acidification |
| Q44999282 | Engineered cell therapy for sustained local myocardial delivery of nonsecreted proteins |
| Q34237622 | Engineering persister-specific antibiotics with synergistic antimicrobial functions |
| Q33246815 | Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides |
| Q38885914 | Enhanced cellular internalization of CdTe quantum dots mediated by arginine- and tryptophan-rich cell-penetrating peptides as efficient carriers |
| Q37198137 | Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo |
| Q46516001 | Evidence that membrane transduction of oligoarginine does not require vesicle formation |
| Q36467417 | Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesis |
| Q36014569 | Fluorogenic Substrates for In Situ Monitoring of Caspase-3 Activity in Live Cells |
| Q40373403 | Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit |
| Q40063020 | Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy |
| Q27021652 | Getting in shape: controlling peptide bioactivity and bioavailability using conformational constraints |
| Q34284076 | Guanidine-Containing Methacrylamide (Co)polymers via aRAFT: Toward a Cell Penetrating Peptide Mimic(). |
| Q42807401 | High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. |
| Q39028900 | Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties |
| Q30564015 | Identification of a novel cell-penetrating peptide from human phosphatidate phosphatase LPIN3 |
| Q33583948 | Impact of hydrogel nanoparticle size and functionalization on in vivo behavior for lung imaging and therapeutics |
| Q36545877 | Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus |
| Q37121611 | Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting |
| Q40369050 | Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides |
| Q39986995 | Membrane transducing activity of recombinant Hoxc8 protein and its possible application as a gene delivery vector |
| Q38628214 | Mitochondria-targeted drug delivery system for cancer treatment |
| Q39455677 | Modulation of the biological activity of microRNA-210 with peptide nucleic acids (PNAs). |
| Q36593381 | Molecular transporters: synthesis of oligoguanidinium transporters and their application to drug delivery and real-time imaging. |
| Q36857036 | Multilayered films fabricated from an oligoarginine-conjugated protein promote efficient surface-mediated protein transduction |
| Q38201740 | Nanomaterials for targeted drug delivery to cancer stem cells |
| Q33726019 | Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. |
| Q44176066 | Neuroprotective effect of TAT PTD-Ngb fusion protein on primary cortical neurons against hypoxia-induced apoptosis |
| Q34247875 | Nona-arginine facilitates delivery of quantum dots into cells via multiple pathways |
| Q40163787 | Noncovalent protein transduction in plant cells by macropinocytosis |
| Q37564527 | Oligoarginine-PEG-lipid particles for gene delivery |
| Q38877676 | Optimal Hydrophobicity in Ring-Opening Metathesis Polymerization-Based Protein Mimics Required for siRNA Internalization. |
| Q35812205 | PTD-Modified ATTEMPTS for Enhanced Toxin-based Cancer Therapy: An In Vivo Proof-of-Concept Study |
| Q36202697 | Peptoid transporters: effects of cationic, amphipathic structure on their cellular uptake |
| Q44939705 | RXLR-mediated entry of Phytophthora sojae effector Avr1b into soybean cells does not require pathogen-encoded machinery |
| Q34991955 | Rational design of a biomimetic cell penetrating peptide library |
| Q35973247 | Real-time analysis of uptake and bioactivatable cleavage of luciferin-transporter conjugates in transgenic reporter mice. |
| Q42151407 | Real-time transmembrane translocation of penetratin driven by light-generated proton pumping |
| Q37784071 | Small-molecule regulators that mimic transcription factors |
| Q39483024 | Structural Elucidation of the Cell-Penetrating Penetratin Peptide in Model Membranes at the Atomic Level: Probing Hydrophobic Interactions in the Blood-Brain Barrier |
| Q51746172 | Synthetic 1-deoxynojirimycin N-substituted peptides offer prolonged disruption to N-linked glycan processing. |
| Q34545352 | Synthetic and natural polycationic polymer nanoparticles interact selectively with fluid-phase domains of DMPC lipid bilayers |
| Q35818922 | TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability. |
| Q36316672 | Targeted drug delivery to mammalian mitochondria in living cells |
| Q42809859 | Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides |
| Q40184296 | Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells. |
| Q26745586 | The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain |
| Q57187330 | The cell-penetrating peptide TAT(48-60) induces a non-lamellar phase in DMPC membranes |
| Q34504298 | The congenital disorders of glycosylation: a multifaceted group of syndromes |
| Q46236828 | The effect of cell penetrating peptides on transfection activity and cytotoxicity of polyallylamine |
| Q38741254 | The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery |
| Q42253045 | The potential role of cell penetrating peptides in the intracellular delivery of proteins for therapy of erythroid related disorders. |
| Q46102626 | The role of apolipoprotein E in uptake of atovaquone into the brain in murine acute and reactivated toxoplasmosis |
| Q35969026 | The use of cell-penetrating peptides for drug delivery |
| Q37429297 | Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients |
| Q37923355 | Transduction of human recombinant proteins into mitochondria as a protein therapeutic approach for mitochondrial disorders |
| Q34340446 | Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems |
| Q92129704 | Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide |
Search more.